94 results
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
15 Aug 24
Other Events
4:02pm
Short Term Operating Lease Liability Long Term Portion of JMB Debt Long Term Operating Lease Liability Long Term Portion of Deferred Sublicense Revenue
8-K
EX-99.2
PHASQ
PhaseBio Pharmaceuticals Inc
12 Jul 24
Bankruptcy or Receivership
4:42pm
Short Term Operating Lease Liability Long Term Portion of JMB Debt Long Term Operating Lease Liability Long Term Portion of Deferred Sublicense
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
12 Jul 24
Bankruptcy or Receivership
4:42pm
, and Other Accrued Interest Short Term Operating Lease Liability Long Term Portion of JMB Debt Long Term Operating Lease Liability Long Term Portion
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
16 May 24
Other Events
4:28pm
of Deferred Sublicense Revenue Accrued Clinical and MFG, and Other Accrued Interest Short Term Operating Lease Liability Long Term Portion of JMB Debt … Long Term Operating Lease Liability Long Term Portion of Deferred Sublicense Revenue Development Derivative Total Liabilities Common Stock APIC
8-K
EX-99.2
PHASQ
PhaseBio Pharmaceuticals Inc
16 May 24
Other Events
4:28pm
, and Other Accrued Interest Short Term Operating Lease Liability Long Term Portion of JMB Debt Long Term Operating Lease Liability Long Term Portion
8-K
EX-99.1
j3p74g1
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-99.3
6g3 nryicz8emr8dj3
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-99.2
pyzeux42o6qp0uhbarqr
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-99.1
5zetl3i rm3
29 Nov 23
Other Events
4:55pm
8-K
EX-99.2
379voie mkpzf
29 Nov 23
Other Events
4:55pm
8-K
EX-99.1
83usn9e
27 Sep 23
Other Events
8:52am
8-K
EX-99.2
hw0ai0a
25 Aug 23
Other Events
12:34pm
8-K
EX-99.1
pq11knhsoq
25 Aug 23
Other Events
12:34pm
8-K
EX-99.1
6imzihd4s8 195cwe8
30 Jun 23
Other Events
4:21pm
8-K
EX-99.1
3u3wi2s4huadss
30 May 23
Other Events
4:02pm
8-K
EX-99.1
yo54zs5yf8o
10 May 23
Other Events
8:08am
8-K
EX-99.1
f8d4wz q8kca28
23 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:33am
8-K
EX-99.1
fwv7 pnlq9b
23 Nov 22
Departure of Directors or Certain Officers
4:08pm
8-K
EX-99.2
azy71
12 Aug 22
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:32am